169 related articles for article (PubMed ID: 38180538)
1. Impact of COVID-19 pandemic on prescription stimulant use among children and youth: a population-based study.
Antoniou T; Pajer K; Gardner W; Penner M; Lunsky Y; McCormack D; Tadrous M; Mamdani M; Gozdyra P; Juurlink DN; Gomes T
Eur Child Adolesc Psychiatry; 2024 Jan; ():. PubMed ID: 38180538
[TBL] [Abstract][Full Text] [Related]
2. Impact of a Publicly-Funded Pharmacare Program on Prescription Stimulant use Among Children and Youth: A Population-Based Observational Natural Experiment.
Antoniou T; McCormack D; Kitchen S; Pajer K; Gardner W; Lunsky Y; Penner M; Tadrous M; Mamdani M; Juurlink DN; Gomes T
Can J Psychiatry; 2023 Nov; 68(11):826-837. PubMed ID: 37016841
[TBL] [Abstract][Full Text] [Related]
3. Impact of the COVID-19 pandemic on antidepressant and antipsychotic use among children and adolescents: a population-based study.
Antoniou T; Pajer K; Gardner W; Penner M; Lunsky Y; Tadrous M; Mamdani M; Gozdyra P; Juurlink DN; Gomes T
Front Pediatr; 2023; 11():1282845. PubMed ID: 38146536
[TBL] [Abstract][Full Text] [Related]
4. Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: a population-based study.
Antoniou T; McCormack D; Kitchen S; Pajer K; Gardner W; Lunsky Y; Penner M; Tadrous M; Mamdani M; Juurlink DN; Gomes T
BMC Public Health; 2023 Jan; 23(1):85. PubMed ID: 36631810
[TBL] [Abstract][Full Text] [Related]
5. Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.
Eaton C; Yong K; Walter V; Mbizvo GK; Rhodes S; Chin RF
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013136. PubMed ID: 35844168
[TBL] [Abstract][Full Text] [Related]
6. Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty - United States, 2014-2019.
Board AR; Guy G; Jones CM; Hoots B
Drug Alcohol Depend; 2020 Dec; 217():108297. PubMed ID: 32961454
[TBL] [Abstract][Full Text] [Related]
7. Impact of a publicly-funded pharmacare program policy on benzodiazepine dispensing among children and youth: a population-based natural experiment.
Antoniou T; McCormack D; Kitchen S; Pajer K; Gardner W; Lunsky Y; Penner M; Tadrous M; Mamdani M; Juurlink DN; Gomes T
BMC Pediatr; 2023 Oct; 23(1):519. PubMed ID: 37858122
[TBL] [Abstract][Full Text] [Related]
8. Use of prescription stimulant for Attention Deficit Hyperactivity Disorder in Aboriginal children and adolescents: a linked data cohort study.
Ghosh M; Holman CD; Preen DB
BMC Pharmacol Toxicol; 2015 Dec; 16():35. PubMed ID: 26646429
[TBL] [Abstract][Full Text] [Related]
9. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
Barner JC; Khoza S; Oladapo A
Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228
[TBL] [Abstract][Full Text] [Related]
10. Trends in Stimulant Prescription Fills Among Commercially Insured Children and Adults - United States, 2016-2021.
Danielson ML; Bohm MK; Newsome K; Claussen AH; Kaminski JW; Grosse SD; Siwakoti L; Arifkhanova A; Bitsko RH; Robinson LR
MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(13):327-332. PubMed ID: 36995976
[TBL] [Abstract][Full Text] [Related]
11. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
Winterstein AG; Gerhard T; Shuster J; Johnson M; Zito JM; Saidi A
Pediatrics; 2007 Dec; 120(6):e1494-501. PubMed ID: 18055666
[TBL] [Abstract][Full Text] [Related]
12. Use of medication by young people with attention-deficit/hyperactivity disorder.
Sawyer MG; Rey JM; Graetz BW; Clark JJ; Baghurst PA
Med J Aust; 2002 Jul; 177(1):21-5. PubMed ID: 12088474
[TBL] [Abstract][Full Text] [Related]
13. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
[TBL] [Abstract][Full Text] [Related]
14. Predictors of concomitant use of antipsychotics and stimulants and its impact on stimulant persistence in pediatric attention deficit hyperactivity disorder.
Bali V; Kamble PS; Aparasu RR
J Manag Care Spec Pharm; 2015 Jun; 21(6):486-98. PubMed ID: 26011550
[TBL] [Abstract][Full Text] [Related]
15. Emergency department use and costs for youth with attention-deficit/hyperactivity disorder: associations with stimulant treatment.
Leibson CL; Barbaresi WJ; Ransom J; Colligan RC; Kemner J; Weaver AL; Katusic SK
Ambul Pediatr; 2006; 6(1):45-53. PubMed ID: 16443183
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder.
Wei YJ; Zhu Y; Liu W; Bussing R; Winterstein AG
JAMA Netw Open; 2018 Aug; 1(4):e181152. PubMed ID: 30646105
[TBL] [Abstract][Full Text] [Related]
17. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
Palli SR; Kamble PS; Chen H; Aparasu RR
J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):139-48. PubMed ID: 22364400
[TBL] [Abstract][Full Text] [Related]
18. Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
Perry BA; Archer KR; Song Y; Ma Y; Green JK; Elefteriou F; Dahir KM
Osteoporos Int; 2016 Jul; 27(7):2223-2227. PubMed ID: 26928186
[TBL] [Abstract][Full Text] [Related]
19. Perinatal Outcomes of Women Diagnosed with Attention-Deficit/Hyperactivity Disorder: An Australian Population-Based Cohort Study.
Poulton AS; Armstrong B; Nanan RK
CNS Drugs; 2018 Apr; 32(4):377-386. PubMed ID: 29557079
[TBL] [Abstract][Full Text] [Related]
20. Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: A population-based study among Australian children and adults (2013-2020).
Bruno C; Havard A; Gillies MB; Coghill D; Brett J; Guastella AJ; Pearson SA; Zoega H
Aust N Z J Psychiatry; 2023 May; 57(5):675-685. PubMed ID: 35999695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
